Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
News
Nature Biotechnology 23, 1455–1456 (1 December 2005) | doi:10.1038/nbt1205-1455
Cord blood cell therapy trial suspended
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
